News Overview

International success: Advanced Accelerator Technologies closes significant deal with Chinese customer

Center for Proton Therapy: Gantry 2 Facility. Photo: © Paul Scherrer Institute (PSI)
Center for Proton Therapy: Gantry 2 Facility. Photo: © Paul Scherrer Institute (PSI)

Did you like this article? Please share it.


Innovation Areas


Advanced Accelerator Technologies AG (AAT), one of the high-tech companies located at PARK INNOVAARE, has finalized a contract with a Chinese company to deliver accelerator diagnostic components and electronics. This success is further proof of the market demand for the rich accelerator technology expertise of the Paul Scherrer Institute (PSI) being commercialized by AAT.

Advanced Accelerator Technologies AG (AAT) was founded in 2015 as a joint initiative of leading Swiss and European industry partners operating in fields related to scientific and industrial equipment (Ampegon AG, Heinz Baumgartner AG, Axilon AG, Cosylab d.d. and VDL ETG). The goal of the initiative was to further develop and commercialize accelerator technologies arising from PSI.

This November, the company successfully won a large contract for delivering accelerator diagnostic components and electronics to a customer in China. “These specific components are designed to monitor the particle beam in a proton therapy facility for medical treatment, and thus the requirements for accuracy and reliability are extremely high,” explains Dr. Udo Klein, CEO of AAT. The Paul Scherrer Institute (PSI) is a pioneer in developing and operating proton therapy installations, and its Center for Proton Therapy runs the world’s first compact scanning gantry for the irradiation of deep-seated tumors with a proton beam. It is also at PSI that the technique of spot-scanning was developed, which allows for an extremely precise irradiation of tumors – thus greatly improving the treatment results.

“This success confirms AAT’s mission of commercializing licensed PSI know-how and thereby creating value for Switzerland and for the Swiss and European partners of AAT,” says Dr. Klein. “We are looking forward to starting work on this project – it’s a true example of technology transfer from science to industry.”